Victory Capital Management
BIVV

Victory Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Victory Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-32
Closed -$2K – 1971
2017
Q4 		$2K Hold
32
– – ﹤0.01% 1814
2017
Q3 		$2K Sell
32
-179
-85% -$10.5K ﹤0.01% 1805
2017
Q2 		$13K Buy
+211
New +$12K ﹤0.01% 1792

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Victory Capital Management's BIVV Position: Q1 2018 in Review

Victory Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 32 shares — an estimated $2K sold.

Victory Capital Management first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $13K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Victory Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Victory Capital Management sold 32 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2K.
  • Victory Capital Management first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
  • Victory Capital Management's Bioverativ Inc. Common Stock position peaked at $13K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Victory Capital Management's 13F filing for Q1 2018, filed 4 May 2018.